AR029436A1 - Compuestos de eteres de dicarboxilato de calcio, metodos para su preparacion y su uso en tratamiento de las enfermedades vasculares y diabetes, composicion farmaceutica, formas cristalinas. - Google Patents

Compuestos de eteres de dicarboxilato de calcio, metodos para su preparacion y su uso en tratamiento de las enfermedades vasculares y diabetes, composicion farmaceutica, formas cristalinas.

Info

Publication number
AR029436A1
AR029436A1 ARP010100284A ARP010100284A AR029436A1 AR 029436 A1 AR029436 A1 AR 029436A1 AR P010100284 A ARP010100284 A AR P010100284A AR P010100284 A ARP010100284 A AR P010100284A AR 029436 A1 AR029436 A1 AR 029436A1
Authority
AR
Argentina
Prior art keywords
preparation
compounds
eteres
diabetes
treatment
Prior art date
Application number
ARP010100284A
Other languages
English (en)
Spanish (es)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of AR029436A1 publication Critical patent/AR029436A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/305Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ARP010100284A 2000-01-25 2001-01-23 Compuestos de eteres de dicarboxilato de calcio, metodos para su preparacion y su uso en tratamiento de las enfermedades vasculares y diabetes, composicion farmaceutica, formas cristalinas. AR029436A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17782300P 2000-01-25 2000-01-25

Publications (1)

Publication Number Publication Date
AR029436A1 true AR029436A1 (es) 2003-06-25

Family

ID=22650106

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100284A AR029436A1 (es) 2000-01-25 2001-01-23 Compuestos de eteres de dicarboxilato de calcio, metodos para su preparacion y su uso en tratamiento de las enfermedades vasculares y diabetes, composicion farmaceutica, formas cristalinas.

Country Status (39)

Country Link
EP (1) EP1259474B1 (https=)
JP (1) JP4750995B2 (https=)
KR (1) KR20020073182A (https=)
CN (1) CN1395555A (https=)
AP (1) AP2002002587A0 (https=)
AR (1) AR029436A1 (https=)
AT (1) ATE431326T1 (https=)
AU (1) AU2214001A (https=)
BG (1) BG106851A (https=)
BR (1) BR0107763A (https=)
CA (1) CA2397960C (https=)
CO (1) CO5261537A1 (https=)
CZ (1) CZ20022474A3 (https=)
DE (1) DE60138686D1 (https=)
DK (1) DK1259474T3 (https=)
DZ (1) DZ3239A1 (https=)
EA (1) EA004862B1 (https=)
EE (1) EE200200404A (https=)
ES (1) ES2324281T3 (https=)
GE (1) GEP20053428B (https=)
GT (1) GT200100015A (https=)
HN (1) HN2001000011A (https=)
HU (1) HUP0204422A3 (https=)
IL (1) IL150541A0 (https=)
IS (1) IS6442A (https=)
MA (1) MA26867A1 (https=)
MX (1) MXPA02007223A (https=)
NO (1) NO20023526L (https=)
NZ (1) NZ519550A (https=)
OA (1) OA12166A (https=)
PA (1) PA8510601A1 (https=)
PE (1) PE20011064A1 (https=)
PL (1) PL357076A1 (https=)
SK (1) SK10622002A3 (https=)
SV (1) SV2002000290A (https=)
TN (1) TNSN01013A1 (https=)
UY (1) UY26550A1 (https=)
WO (1) WO2001055078A1 (https=)
ZA (1) ZA200205880B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481962A1 (en) * 1997-12-12 2004-12-01 Warner-Lambert Company LLC New cholesterolemia-lowering carboxyalkylether compound
MXPA05001254A (es) * 2002-08-22 2005-06-08 Warner Lambert Co Procedimiento para el tratamiento de la osteoartritis.
EP1873141A4 (en) * 2005-04-19 2010-09-22 Eisai R&D Man Co Ltd CALCIUM-BIS [2S] -3- [3- (2S) -3- (4-CHLORO-2-CYANOPHENOXY) -2-FLUORO-PROPOXYPHENYL] -2-ISOPROPOXYPROPIONATE] AND INTERMEDIATE PRODUCTS THEREOF
US7816405B2 (en) 2005-04-19 2010-10-19 Eisai R&D Management Co., Ltd. Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof
WO2016077832A2 (en) * 2014-11-14 2016-05-19 Gemphire Therapeutics Inc. PROCESSES AND INTERMEDIATES FOR PREPARING α,ω-DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS
EP3612171A4 (en) 2017-04-18 2020-10-21 Gemphire Therapeutics Inc. GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND PROCEDURES FOR THE USE OF THE SAME
WO2020081837A1 (en) * 2018-10-18 2020-04-23 Gemphire Therapeutics Inc. Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use therefor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
NZ503982A (en) 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
MA26867A1 (fr) 2004-12-20
EP1259474A1 (en) 2002-11-27
ES2324281T3 (es) 2009-08-04
EE200200404A (et) 2003-10-15
CN1395555A (zh) 2003-02-05
ZA200205880B (en) 2003-07-23
OA12166A (en) 2003-11-07
CA2397960A1 (en) 2001-08-02
EP1259474B1 (en) 2009-05-13
PA8510601A1 (es) 2002-08-26
NO20023526L (no) 2002-08-27
UY26550A1 (es) 2001-08-27
SK10622002A3 (sk) 2003-07-01
ATE431326T1 (de) 2009-05-15
GEP20053428B (en) 2005-01-25
SV2002000290A (es) 2002-07-16
WO2001055078A1 (en) 2001-08-02
HUP0204422A2 (en) 2003-05-28
AU2214001A (en) 2001-08-07
PL357076A1 (en) 2004-07-12
DE60138686D1 (de) 2009-06-25
IL150541A0 (en) 2003-02-12
CZ20022474A3 (cs) 2003-06-18
JP2003520835A (ja) 2003-07-08
GT200100015A (es) 2001-10-19
TNSN01013A1 (fr) 2005-11-10
NZ519550A (en) 2003-11-28
BR0107763A (pt) 2002-11-12
DK1259474T3 (da) 2009-07-20
AP2002002587A0 (en) 2002-09-30
EA200200641A1 (ru) 2002-12-26
EA004862B1 (ru) 2004-08-26
CO5261537A1 (es) 2003-03-31
NO20023526D0 (no) 2002-07-24
DZ3239A1 (fr) 2001-08-02
CA2397960C (en) 2008-09-09
HUP0204422A3 (en) 2003-08-28
MXPA02007223A (es) 2002-11-29
JP4750995B2 (ja) 2011-08-17
KR20020073182A (ko) 2002-09-19
PE20011064A1 (es) 2001-10-22
IS6442A (is) 2002-06-25
HN2001000011A (es) 2001-06-13
BG106851A (en) 2003-01-31

Similar Documents

Publication Publication Date Title
ES2013067A6 (es) Un procedimiento para producir un derivado de piperazina.
EA200601584A1 (ru) Замещённые глюкопиранозилом бензольные производные, содержащие эти соединения лекарственные средства, их применение и способ их получения
PA8609201A1 (es) Piridinonas sustituidas
AR033499A1 (es) Derivado de quinazolina, proceso para su preparacion, composicion farmaceutica que lo comprende y su uso en la fabricacion de medicamentos para usar en la produccion de un efecto antiangeogenico y/o reductor de la permeabilidad vascular en un animal de sangre caliente
BR9916790A (pt) Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente
AR041932A1 (es) Derivados de ciclohexano espirociclicos, preparacion de los mismos, su uso en la fabricacion de medicamentos y dichos medicamentos.
DOP2006000084A (es) Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos compuestos, metodos de preparacion y usos de los mismos
AR037517A1 (es) Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
AR031248A1 (es) Compuestos de ditosilato de quinazolina, composicion farmaceutica, metodo de tratamiento y uso en terapia y proceso para la preparacion de dichos compuestos
ES2017837A6 (es) Un procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
AR003440A1 (es) Nuevos derivados de aminoacidos, formulacion farmaceutica que los contiene, uso de dichos derivados para preparar medicamentos y procedimiento para la preparacion de dichos derivados.
UY26956A1 (es) Derivados del pirazol para el tratamiento de enfermedades virales
BRPI0411673A (pt) composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto
EP1373207A4 (en) NEW AMLODIPINCAMSYLATE AND METHOD FOR THE PRODUCTION THEREOF
IT1251166B (it) Derivati di geneserina,loro preparazione e composizioni farmaceutiche che li contengono
ATE427944T1 (de) Isoflavonderivative von tectoridin, deren herstellung und antivirale medikamente, die diese als wirksame bestandteile enthalten
AR029436A1 (es) Compuestos de eteres de dicarboxilato de calcio, metodos para su preparacion y su uso en tratamiento de las enfermedades vasculares y diabetes, composicion farmaceutica, formas cristalinas.
MX9307363A (es) Compuestos de 2-nitroarilo y 2-cianoarilo y composiciones farmaceuticas que los contienen.
DE502005008971D1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht
AR035465A1 (es) Compuestos de imidazopiridina, procesos para su preparacion,formulacion farmaceutica, usos de estos compuestos para la fabricacion de medicamentos e intermediarios
ES2318023T3 (es) Uso de derivados de acidos 2,5-dihidroxibenceno-sulfonicos en la elaboracion de un medicamento para potenciar el efecto de otros farmacos en el tratamiento de la disfuncion erectil.
PA8525801A1 (es) Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2
AR032622A1 (es) Compuestos de 4-amino-azepan-3-ona, composiciones farmaceuticas que los comprenden, intermediarios utiles en la sintesis de tales compuestos, procedimiento para la sintesis de dichos compuestos, y uso de tales compuestos en la fabricacion de medicamentos
BRPI0417179A (pt) gentisato de amlodipina, método de preparar o mesmo e composição farmacêutica para tratamento de doenças cardiovasculares
ATE3552T1 (de) Verfahren zur herstellung von phosphono-hydroxy- essigsaeure und salzen derselben sowie diese enthaltende autivirale mittel.

Legal Events

Date Code Title Description
FB Suspension of granting procedure